Abstract
Anabolic-androgen steroids (AASs) are the primary drug class in a larger pattern of drug use designed to improve one’s appearance or alter their ability to perform in athletic or other competitive environments. The use of these substances has evolved tremendously in the last century. The evolution of this form of drug use has been aided by the advancements in the understanding of the basic neuroscience of androgen effects in the central nervous system (CNS). This chapter summarizes the current knowledge on the psychiatric effects of AASs and the theoretical and preclinical models that support the possibility for AAS intoxication and dependence. Emerging evidence suggests that these two aspects of AAS use are mediated by distinct neuroendocrine events involving drug metabolism into other active androgens or estrogens and the ability of AASs to stimulate natural opiates and inhibit stress response. This latter effect is also linked to the neuroendocrine effects of intense exercise, which are mimicked by AAS use. Future directions for preclinical, translational, and clinical research are discussed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Clark AS, Henderson LP (2003) Behavioral and physiological responses to anabolic-androgenic steroids. Neurosci Biobehav Rev 27(5):413–436
Hildebrandt T, Langenbucher JW, Carr SJ et al (2007) Modeling population heterogeneity in appearance- and performance-enhancing drug (APED) use: applications of mixture modeling in 400 regular APED users. J Abnorm Psychol 116(4):717–733
Hildebrandt T, Lai JK, Langenbucher JW et al (2011) The diagnostic dilemma of pathological appearance and performance enhancing drug use. Drug Alcohol Depend 114(1):1–11
Kanayama G, Brower KJ, Wood RI et al (2009) Anabolic-androgenic steroid dependence: an emerging disorder. Addiction 104(12):1966–1978
Kicman AT (2008) Pharmacology of anabolic steroids. Br J Pharmacol 154(3):502–521
McGinnis MY (2004) Anabolic androgenic steroids and aggression: studies using animal models. Ann N Y Acad Sci 1036:399–415
Peters KD, Wood RI (2005) Androgen dependence in hamsters: overdose, tolerance, and potential opioidergic mechanisms. Neuroscience 130(4):971–981
Wood RI (2008) Anabolic-androgenic steroid dependence? Insights from animals and humans. Front Neuroendocrinol 29(4):490–506
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 Springer Science+Business Media, LLC, part of Springer Nature
About this entry
Cite this entry
Hildebrandt, T. (2022). Abuse of Performance-Enhancing Drugs. In: Pfaff, D.W., Volkow, N.D., Rubenstein, J.L. (eds) Neuroscience in the 21st Century. Springer, Cham. https://doi.org/10.1007/978-3-030-88832-9_109
Download citation
DOI: https://doi.org/10.1007/978-3-030-88832-9_109
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-88831-2
Online ISBN: 978-3-030-88832-9
eBook Packages: Biomedical and Life SciencesReference Module Biomedical and Life Sciences